Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Richard Voellmy, David C Bloom & Nuria Vilaboa. (2015) A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virus. Expert Review of Vaccines 14:5, pages 637-651.
Read now
Read now
Articles from other publishers (20)
Xinyue Deng, Yinan Shen, Ming Yi, Chaomei Zhang, Bin Zhao, Guansheng Zhong, WeiyangLou, Dixuan Xue, Qi Leng, Jun Ding, Ronghua zhao, Weiguo Jia, Chenfang Dong & Zhijun Dai. (2023) Combination of novel oncolytic herpesvirus with paclitaxel as an efficient strategy for breast cancer therapy. Journal of Medical Virology 95:5.
Crossref
Crossref
Pooya Farhangnia, Shamim Mollazadeh Ghomi, Shabnam Mollazadehghomi & Ali-Akbar Delbandi. 2023. Gastrointestinal Cancers: An Interdisciplinary Approach. Gastrointestinal Cancers: An Interdisciplinary Approach
327
380
.
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Crossref
Maryum Nisar, Rehan Zafar Paracha, Sidra Adil, Sumair Naseem Qureshi & Hussnain Ahmed Janjua. (2022) An Extensive Review on Preclinical and Clinical Trials of Oncolytic Viruses Therapy for Pancreatic Cancer. Frontiers in Oncology 12.
Crossref
Crossref
Monika A. Papież & Wirginia Krzyściak. (2021) Biological Therapies in the Treatment of Cancer—Update and New Directions. International Journal of Molecular Sciences 22:21, pages 11694.
Crossref
Crossref
Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary & Nada Zaidan. (2021) Oncolytic Herpes Simplex Virus-Based Therapies for Cancer. Cells 10:6, pages 1541.
Crossref
Crossref
Richard Voellmy, David C Bloom & Nuria Vilaboa. (2020) Herpes Simplex Viruses Whose Replication Can Be Deliberately Controlled as Candidate Vaccines. Vaccines 8:2, pages 230.
Crossref
Crossref
David C. Bloom, Robert K. Tran, Joyce Feller & Richard Voellmy. (2018) Immunization by Replication-Competent Controlled Herpesvirus Vectors. Journal of Virology 92:16.
Crossref
Crossref
David C. Bloom, Joyce Feller, Peterjon McAnany, Nuria Vilaboa & Richard Voellmy. (2015) Replication-Competent Controlled Herpes Simplex Virus. Journal of Virology 89:20, pages 10668-10679.
Crossref
Crossref
Thomas B. Lentz, Steven J. Gray & R. Jude Samulski. (2012) Viral vectors for gene delivery to the central nervous system. Neurobiology of Disease 48:2, pages 179-188.
Crossref
Crossref
T T Sahin, H Kasuya, N Nomura, T Shikano, K Yamamura, T Gewen, A Kanzaki, T Fujii, T Sugae, T Imai, S Nomoto, S Takeda, H Sugimoto, T Kikumori, Y Kodera, Y Nishiyama & A Nakao. (2011) Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer. Cancer Gene Therapy 19:4, pages 229-237.
Crossref
Crossref
Cecilia Larocca & Jeffrey Schlom. (2011) Viral Vector-Based Therapeutic Cancer Vaccines. The Cancer Journal 17:5, pages 359-371.
Crossref
Crossref
Stuart McCaighy. (2009) A comparative review of the potential role of adenovirus and Herpes Simplex Virus in the treatment of advanced squamous cell carcinoma of the head and neck. Journal of Radiotherapy in Practice 8:3, pages 147-155.
Crossref
Crossref
Z. Q. Han, M. Assenberg, B. L. Liu, Y. B. Wang, G. Simpson, S. Thomas & R. S. Coffin. (2007) Development of a second‐generation oncolytic Herpes simplex virus expressing TNFα for cancer therapy. The Journal of Gene Medicine 9:2, pages 99-106.
Crossref
Crossref
Zoran Gojkovic & Anna Karlsson. 2007. Deoxynucleoside Analogs In Cancer Therapy. Deoxynucleoside Analogs In Cancer Therapy
403
439
.
Douglas W. Grosenbach, Jarett Feldman, Jeffrey Schlom & Scott I. Abrams. 2007. General Principles of Tumor Immunotherapy. General Principles of Tumor Immunotherapy
217
250
.
Y Shen & J Nemunaitis. (2006) Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Therapy 13:11, pages 975-992.
Crossref
Crossref
Prasad S. Adusumilli, David P. Eisenberg, Brendon M. Stiles, Sun Chung, Mei-Ki Chan, Valerie W. Rusch & Yuman Fong. (2006) Intraoperative localization of lymph node metastases with a replication-competent herpes simplex virus. The Journal of Thoracic and Cardiovascular Surgery 132:5, pages 1179-1188.e1.
Crossref
Crossref
Jeff L. Hummel, Ekaterina Safroneeva & Karen L. Mossman. (2005) The role of ICP0-Null HSV-1 and interferon signaling defects in the effective treatment of breast adenocarcinoma. Molecular Therapy 12:6, pages 1101-1110.
Crossref
Crossref
Khalid Ahmed Al‐Anazi, Asma Marzouq Al‐Jasser & David Alan Price Evans. (2005) Effect of varicella zoster virus infection on bone marrow function. European Journal of Haematology 75:3, pages 234-240.
Crossref
Crossref